EXCILITE-µ Vitiligo Psoriasis Atopic Dermatitis Alopecia Areata Mycosis Fungoides Fast, Practical and Effective: a Complete System for Targeted and Selective Phototherapy MEL@308 nm Source: the Advantages of Short and Effective Treatments

PROGRESSIVE ACTION TO COMBAT VITILIGO AND PSORIASIS: NO DRUGS, PAINLESS, RAPID. Vitiligo and psoriasis cause millions of people physical and psychological discomfort. Costly treatments which have to be repeated over time and serious side effects have dashed the hopes of many patients. Now the innovative Monochromatic Excimer Light (MEL@308 nm) of Excilite-μ offers a revolutionary way of treating vitiligo and psoriasis. The introduction of the MEL@308 nm source for Targeted Phototherapy marks a decisive breakthrough on traditional treatments with NB UVB sources. This new technology, developed...

EXCILITE-µ TARGETED PHOTOTHERAPY WITH EXCILITE-µ: REAL BENEFITS IN TREATING VITILIGO AND PSORIASIS Vitiligo and psoriasis are common disorders, affecting 2-3% of the world population. Studies on the quality of life confirm that they are among the most psychologically devastating diseases, with dramatic effects on the patient’s social life. Excilite-μ is the ideal solution for restoring well-being in just a few sessions. Targeted and Selective Phototherapy: Advantages for Patients and Physicians Alike Excilite-µ offers a number of important advantages for treating vitiligo and psoriasis: The special...

EXCILITE-µ: THE ADVANTAGES OF A COMPACT SYSTEM WITH EXCLUSIVE TECHNOLOGY Excilite-µ combines the advantages of advanced technology with a practical and functional design. Like laser, Excilite-µ has a monochromatic emission with the same wavelength of 308 nm and high intensity (50 mW/cm2). However, compared to excimer laser sources, Excilite-μ offers significant advantages: • It can treat much larger areas (30 cm2) in a uniform manner, thanks to a larger handpiece. This means that treatment times can be significantly reduced. • Thanks to the sealed source, the costly or complex maintenance operations...

The rapid modifications of the inflammatory infiltrate also involve several other molecules such as p53, mediator of the apoptotic process, the expression of which rapidly increases after treatment, while the antiapoptotic protein Bcl-2 shows a reduced expression. Ki-67 the protein that determines the cellular , proliferation index which usually increases in the case of psoriasis (A), already shows a reduced expression 48 hours after a single treatment (B). EXCILITE-µ: A POLYVALENT TECHNOLOGY FOR TREATING SKIN PATHOLOGIES Beyond the treatment of Psoriasis and Vitiligo, Excilite-µ has also proved...

TECHNICAL DATA MEL@308, Excimer XeCl Power Density Emission Treatment Surfaces Rectangular: 30 cm2 (5x6 cm) max. Rectangular: 6 cm2 (2x3 cm) Circular: 0.8 cm2 (ø 1 cm) min Control Panel Electrical Requirements Dimensions Weight LCD Color Touch Screen 230 Vac / 2.6 A (max.) / 50 - 60 Hz 24 cm (H) x 38 cm (W) x 50 cm (D) 19 Kg This brochure is not intended for the market of USA. VITILIGO - PSORIASIS - ATOPIC DERMATITIS ALOPECIA AREATA - MYCOSIS FUNGOIDES Dealer stamp www.dekalaser.com DEKA M.E.L.A. s.r.l. Via Baldanzese,17 - 50041 Calenzano (FI) - Italy Tel. +39 055 8874942 - Fax +39 055 8832884...